Health & Fitness News October 31, 2024 Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs October 31, 2024 Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall October 30, 2024 CDC says 90 people affected in E. coli outbreak linked to McDonald’s Quarter Pounders October 30, 2024 Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says October 30, 2024 Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed October 30, 2024 Fired Disney employee allegedly hacked menu system to falsely claim certain foods did not contain peanuts, complaint says October 30, 2024 We're hiking our GEHC price target, looking beyond a mixed quarter to next year's catalysts October 30, 2024 Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction October 30, 2024 Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance « Previous 1 2 3 4 5 6 7 8 9 … 18 19 20 21 Next »
October 31, 2024 Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
October 31, 2024 Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
October 30, 2024 CDC says 90 people affected in E. coli outbreak linked to McDonald’s Quarter Pounders
October 30, 2024 Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
October 30, 2024 Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
October 30, 2024 Fired Disney employee allegedly hacked menu system to falsely claim certain foods did not contain peanuts, complaint says
October 30, 2024 We're hiking our GEHC price target, looking beyond a mixed quarter to next year's catalysts
October 30, 2024 Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
October 30, 2024 Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance